Revvity Inc. stock extends rally after 52-week high and strong S&P 500 outperformance

Published on 09/17/2026 at 14:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revvity Inc. stock closed at USD 140.19 on the NYSE on September 16, 2026, up 9.1 percent and touching a 52-week high near USD 140.21. The move caps a 25.4 percent one-month gain and comes ahead of the next earnings date on October 26, 2026.

Labor mit Wissenschaftlerin an Sequenziergerät und Reagenzflaschen — Fotorealistisches Life-Sciences-Labor zeigt Revvity Inc. (ISIN US76155R1086) mit automatisiertem Sequenziergerät und Reagenzien, Illustration mit AI erstellt.

Revvity Inc. stock (ISIN US76155R1086) closed at USD 140.19 on the New York Stock Exchange on September 16, 2026, gaining 9.1 percent versus the prior session and finishing essentially at its 52-week high of USD 140.21.

Revvity stock rallies to a new 52-week high

According to Ad-hoc news, Revvity Inc. (NYSE: RVTY) ended the September 16, 2026 session at USD 140.19, up 9.1 percent on the day, while the S&P 500 index fell about 0.6 percent in the same session.

As RTTNews reported, Revvity shares reached an intraday 52-week high of USD 140.21 on September 16, 2026, with the close essentially matching that peak and underscoring strong demand despite weakness in the broader market.

Momentum and valuation context for Revvity stock

A performance overview from Trefis on September 17, 2026 highlights that Revvity stock has gained 25.4 percent over the last month, marking the strongest one-month run among the five S&P 500 constituents that recently set new 52-week highs.

The same Trefis analysis notes that Revvity trades at 68.5 times trailing earnings, with revenue up 4.1 percent over the last twelve months and an operating margin of 12.3 percent in that period, providing investors with a quantified view of growth and profitability relative to the stock’s elevated valuation.

Another performance snapshot from Benzinga on September 16, 2026 indicates that Revvity currently has a market capitalization of approximately USD 16.24 billion based on a share price of USD 145.52 at the time of writing, illustrating the company’s mid-cap scale within the US health sciences space.

Upcoming earnings date and insider share sale

Looking ahead, investors are focusing on the next fundamental checkpoint. According to the earnings calendar cited by Ad-hoc news, Revvity is scheduled to report its upcoming quarterly results on October 26, 2026 before the market open, a date that many market participants view as the next major catalyst for the stock.

In parallel with the share price strength, insider activity provides additional context. A Form 144 notice summarized by StockTitan on September 16, 2026 states that Revvity officer Tajinder S. Vohra plans to sell up to 7,330 shares of common stock on the NYSE under Rule 144, with an aggregate market value of USD 1,032,650.40 based on the price information used in the filing.

The same SEC-related summary notes that Revvity had 111,586,401 common shares outstanding as of September 16, 2026, so the planned sale represents a very small fraction of the total share count and is unlikely to materially affect the company’s ownership structure in isolation.

Revvity stock price level and trading venue

As of the most recently completed session on September 16, 2026, Revvity Inc. stock traded at USD 140.19 on the New York Stock Exchange, placing it effectively at its 52-week high of USD 140.21 and reflecting a 9.1 percent single-day move from the prior close.